If we start with the objective of providing equitable access to these therapies, how they are evaluated is only one question. In fact, in the emerging era of personalised medicine, it may be the easiest question to answer. …
Latest Video
New Stories
-
The 'post-rebate' era has started with or without supply chain reform
August 23, 2019 - - Latest News -
Is there even a plan for emerging therapies in Australia?
August 23, 2019 - - Latest News -
Federal government still finalising CAR-T agreement with Peter Mac
August 23, 2019 - - Latest News -
EBOS looking to 'the next wave of growth'
August 23, 2019 - - Latest News -
Bayer makes another move into cell therapy
August 22, 2019 - - Latest News -
Government could come for more given savings shortfall
August 22, 2019 - - Latest News -
Patients might be hoping their medicine belongs to a large company
August 22, 2019 - - Latest News